Biblio

Author Title Type [ Year

]

Filters: Author is Wang, Yu [Clear All Filters]

2024

Liang M, Lyu Z-S, Zhang Y-Y, Tang S-Q, Xing T, Chen Y-H, Wang Y, Jiang Q, Xu L-P, Zhang X-H, et al. Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury. Cancer Lett. 2024:216937.

Ma C, Chen P, Du J, Wang L, Lu N, Sun J, Qilong X, Wang Y, Dou L, Liu D-H. Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation. J Immunother Cancer. 2024;12(1).

Hu L, Li Z, Yang S, Zhao T, Duan W, Qin Y, Jia J, Wang J, Lu S, Jiang H, et al. Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemia. Ann Hematol. 2024.

Wang Y, Narasimamurthy R, Qu M, Shi N, Guo H, Xue Y, Barker N. Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis. Nat Cancer. 2024.

Fan S, Mo X, Zhang X, Xu L, Wang Y, Yan C, Chen H, Zhang Y, Cheng Y, Sun Y, et al. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study. Ann Hematol. 2024.

Wang L-Y, Li Y, Jiang Q, Jiang H, Wang Y, Xu L-P, Zhang X-H, Liu K-Y, Tang F-F. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis. Hematol Oncol. 2024;42(2):e3256.

Tang F, Wang Y, Wang Y, Jin J, Han W, Chen Y, Yan C, Xu L, Zhang X, Huang X. The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome. Clin Exp Med. 2024;24(1):33.

Cheng C, Deng D-X, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, et al. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment. Front Oncol. 2024;14:1390438.

Jin S, Zhang W, Zeng W, Zhang Y, Feng J, Wang Y, Luo H, Liu T, Lu H. In vitro differentiation of human amniotic epithelial stem cells into keratinocytes regulated by OPN3. Exp Dermatol. 2024;33(1):e15007.

Fu H, Sun X, Lin R, Wang Y, Xuan L, Yao H, Zhang Y, Mo X, Lv M, Zheng F, et al. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial. BMC Med. 2024;22(1):85.

Wang Y, Liu Q-F, Wu D-P, Xu Z-L, Han T-T, Sun Y-Q, Huang F, Fan Z-P, Xu N, Chen F, et al. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC Med. 2024;22(1):176.

Cao Y, Huo W, Huang J, Yang Y, Wang Y, Chang Y, Wang L, Zhang Z, Jiang C, Hu X, et al. MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study. Blood Cancer J. 2024;14(1):8.

Wu L, Chen L, Li H, Wang Y, Xu K, Chen W, Zhang A, Wang Y, Shi C. Nocardia rubra cell-wall skeleton mitigates whole abdominal irradiation-induced intestinal injury via regulating macrophage function. Burns Trauma. 2024;12:tkad045.

Hu G-H, Zhang X-H, Liu K-Y, Xu L-P, Wang Y, Cheng Y-F, Huang X-J. Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive acute lymphoblastic leukemia. Acta Haematol. 2024.

Shang Q, Bai L, Cheng Y, Suo P, Hu G, Yan C, Wang Y, Zhang X, Xu L, Liu K, et al. Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia. Bone Marrow Transplant. 2024.

Hu G-H, Zhang X-H, Wang Y, Xu L-P, Hou X-L, Cheng Y-F, Huang X-J. The prognosis of haploidentical hematopoietic stem cell transplantation in infants and patients under 3 years old with acute leukemia. Clin Transplant. 2024;38(2):e15247.

Xiao M, Zhou J, Zhu X, He Y, Wang F, Zhang Y, Mo X, Han W, Wang J, Wang Y, et al. A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2024.

Wang Y, Narasimamurthy R, Qu M, Shi N, Guo H, Xue Y, Barker N. Publisher Correction: Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis. Nat Cancer. 2024.

Wang Q, Tan X, Wang Y, Zhang D, Li X, Liu S. The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers. J Adv Res. 2024.

Ma R, Zhu D-P, Zhang X-H, Xu L-P, Wang Y, Mo X-D, Lv M, Zhang Y-Y, Cheng Y-F, Yan C-H, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transplant. 2024.

2023

Sun L, Ji Y, Chi B, Xiao T, Li C, Yan X, Xiong X, Mao L, Cai D, Zou A, et al. A 3D culture system improves the yield of MSCs-derived extracellular vesicles and enhances their therapeutic efficacy for heart repair. Biomed Pharmacother. 2023;161:114557.

Li H, Li R, He S, Wang Y, Fang W, Jin Y, Yang R, Liu Y, Ye Q, Peng X. An Aptamer-Embedded Two-Dimensional DNA Nanoscale Material with the Property of Cells Recruitment. Nano Lett. 2023.

Kong J, Zheng F-M, Wang Z-D, Zhang Y-Y, Cheng Y-F, Fu H-X, Lv M, Chen H, Xu L-P, Zhang X-H, et al. Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.

Wei S, Wang Y, Sun Y, Gong L, Dai X, Meng H, Xu W, Ma J, Hu Q, Ma X, et al. Biodegradable silk fibroin scaffold doped with mineralized collagen induces bone regeneration in rat cranial defects. Int J Biol Macromol. 2023:123861.

Zhao X, Wu H, Cheng Y, Xu Z, Chen Y, Chang Y, Wang Y, Zhang X, Xu L, Huang X. Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia. Chin Med J (Engl). 2023.

Pages